13G Filing: Stonepine Capital Management, LLC Details Ownership of Vanda Pharmaceuticals Inc. (VNDA)

Page 6 of 8 SEC Filing

Item 1.

(a) Name of Issuer

Vanda Pharmaceuticals Inc.

(b) Address of Issuer’s Principal
Executive Offices

2200 Pennsylvania Avenue NW, Suite 300E, Washington, DC 20037

Item 2.

(a) The names of the persons filing this statement are:

Stonepine Capital, L.P., a Delaware limited partnership (the “Fund”)

Stonepine Capital Management, LLC,
a California limited liability company (the “General Partner”)

Jon M. Plexico

Timothy P. Lynch (collectively,
the “Filers”)

(b) The principal business office of the Filers is located at

P.O Box 250

Bend, OR 97709

(c) For citizenship of Filers, see Item 4 of the cover sheet for each Filer.
(d) This statement relates to the Issuer’s Common Stock (the “Stock”).
(e) The CUSIP number of the Issuer is: 921659108
6

Follow Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)